Frontiers in Cardiovascular Medicine (Oct 2023)

From multi-omics approaches to personalized medicine in myocardial infarction

  • Chaoying Zhan,
  • Tong Tang,
  • Erman Wu,
  • Yuxin Zhang,
  • Yuxin Zhang,
  • Mengqiao He,
  • Rongrong Wu,
  • Cheng Bi,
  • Cheng Bi,
  • Jiao Wang,
  • Yingbo Zhang,
  • Yingbo Zhang,
  • Bairong Shen

DOI
https://doi.org/10.3389/fcvm.2023.1250340
Journal volume & issue
Vol. 10

Abstract

Read online

Myocardial infarction (MI) is a prevalent cardiovascular disease characterized by myocardial necrosis resulting from coronary artery ischemia and hypoxia, which can lead to severe complications such as arrhythmia, cardiac rupture, heart failure, and sudden death. Despite being a research hotspot, the etiological mechanism of MI remains unclear. The emergence and widespread use of omics technologies, including genomics, transcriptomics, proteomics, metabolomics, and other omics, have provided new opportunities for exploring the molecular mechanism of MI and identifying a large number of disease biomarkers. However, a single-omics approach has limitations in understanding the complex biological pathways of diseases. The multi-omics approach can reveal the interaction network among molecules at various levels and overcome the limitations of the single-omics approaches. This review focuses on the omics studies of MI, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, and other omics. The exploration extended into the domain of multi-omics integrative analysis, accompanied by a compilation of diverse online resources, databases, and tools conducive to these investigations. Additionally, we discussed the role and prospects of multi-omics approaches in personalized medicine, highlighting the potential for improving diagnosis, treatment, and prognosis of MI.

Keywords